IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Skip to Content MayoACCESS MayoLINK...
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732
MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular
January 2023 - Biochemical Genetics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Biochemical Genetics.
Cardiology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and cardiology patient-care clinics allows us to reduce downstream costs with care-driven...
CPT codes and LOINC update: January 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of January.
People Archives - Page 3 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Mayo Clinic Team to Combat Arboviruses and Future Infectious Disease Threats in Belize - Insights
Mayo Clinic and the University of Notre Dame’s Eck Institute for Global Health have launched a four-tiered joint project to better characterize and further assist in the detection of vector-borne infectious diseases in Belize.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
December 2022 - Renal - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal Pathology.
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Browse our full menu of individual tests and panels that aid in the diagnosis of tick-borne diseases.
Mayo Clinic Laboratories’ robust portfolio of clinically supported assays to test for marijuana use is consistent with professional recommendations.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Revolutionizing Endometrial Cancer Diagnostics - Insights
Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...
Clinical excellence - Insights
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
Transformative diagnostics - Insights
With a sophisticated laboratory test catalog and thousands of Mayo Clinic experts, we’re here to help you answer the toughest clinical questions.
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
Infectious diseases - Insights
Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our...
Infectious Diseases - Insights
Learn how our clinical microbiology laboratory can aid in diagnosing pediatric illnesses caused by insects, fungal species, and parasites.
Therapeutics events - Insights
TherapeuticS Creating the new standard of therapeutic management, together Mayo Clinic Laboratories’ evidence-based toxicology and pharmacogenomic testing
Hospitals and health systems - Insights
Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.
Mayo Clinic Laboratories works closely with group purchasing organizations (GPOs) and purchasing groups (PGs) to provide clients access to our esoteric tests and services, delivering solutions that drive efficiency.
Commercial laboratories - Insights
Mayo Clinic Laboratories is a one stop laboratory solution for commercial laboratories, offering the industry’s most comprehensive test menu, 24/7 customer service support and streamlined logistics to help clients meet their business goals.
A Mayo Clinic BioPharma Diagnostics engagement offers partners access to Mayo Clinic Laboratories’ robust library of hematology evaluations.
Integration, innovation, precision: Propelling leading-edge diagnostics - Insights
The third episode of “Life of a Specimen” video series discusses the integration that drives the development of innovative tests, including the movement disorders evaluation, at Mayo Clinic Laboratories.
The exponential increase in the number of diagnostic tests available to physicians (in dermatopathology as well as other medical specialties) can be overwhelming, according to a new multi-institutional study co-published in the Journal of...
MCL Gastroenterology and Hepatology Test Request Form MC076710A
MCL Gastroenterology Hepatology Test Request Form Complete print Reset Form Gastroenterology Hepatology Test Request Client Information required Client Client Account Client Phone
Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
New tests launched in June - Insights
In June 2022, Mayo Clinic Laboratories announced forty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose. To provide meaningful answers, our...
What's New in Health Care Reform: Jan. 23 - Insights
Top highlights include: Physician burnout now essentially a public health crisis, Americans more likely to die from opioid overdose than in a car accident, study identifies biomarkers to stratify patients for prostate cancer treatment, the...
What's New in Health Care Reform: Jan. 30 - Insights
Top highlights include: Alcohol overtakes Hepatitis C as the top reason for liver transplants, new research call vitamin D benefits into question, NIH funds first artificial pancreas study in the United States for pregnant women, cervical...
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...